Trial Profile
Etanercept biosimilar Infinitam in patients with moderate-to-severe rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jun 2013
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 25 Jun 2013 New trial record
- 15 Jun 2013 Primary endpoint 'Disease-activity-score' has been met.
- 15 Jun 2013 Results presented at the 14th Annual Congress of the European League Against Rheumatism.